Evidence map›Paper›PMID 39710922›Full record

ArticleInfectious disorders drug targets2025

Maryam Pourhajibagher, Abbas Bahador

Abstract read
PubMed Publisher
In one paragraph

Article in Infectious disorders drug targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maryam PourhajibagherDental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abbas BahadorDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Funding

Dental Research Center, Dentistry Research Institute, Tehran University of Medical Science and Health Services 1402-4-134-68410
6 · The paper itself

Abstract

introductionBiosurfactants are naturally occurring compounds with various applications, biodegradable, non-toxic, and effective in different conditions. This study focuses on the extraction and evaluation of biosurfactants produced by five strains of lactic acid bacteria (LAB) for their potential to inhibit biofilm formation and adhesion by

methodsThe strains of LAB-producing biosurfactants such as

resultsThe study found that LAB-derived biosurfactants exhibit significant anti-adhesion and anti-biofilm activities against

conclusionThese promising bioactive compounds can be utilized as natural antimicrobial agents and biofilm inhibitors to prevent microbial biofilm formation and adhesion in various dental applications, offering a safe and effective alternative for controlling dental biofilms and improving oral health outcomes.

Indexed as

Anti-Bacterial AgentsBacterial AdhesionBiofilmsLactobacillalesLactobacillusStreptococcus mutansSurface-Active AgentsBiosurfactantsCell LineFibroblastsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsSurface-Active AgentsbiofilmBiosurfactanthydrophilichydrophobic.lactic acid bacteriaStreptococcus mutans

Identifiers

PMID39710922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.